HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Noronha, A. B. C. Articles by Medof, M. E. Search for Related Content PubMed PubMed Citation Articles by Noronha, A. B. C. Articles by Medof, M. E.

Circulating immune complexes in neurologic disease

Departments of Neurology (Drs. Noronha, Antel, and Roos) and Medicine (Dr. Medof), Division of the Biological Sciences, the University of Chicago, and the Pritzker School of Medicine, Chicago, IL.

Address correspondence and reprint requests to Dr. Medof, Department of Medicine, the University of Chicago, 950 E. 59th Street, Box 404, Chicago, IL 60637.

Sera from patients with multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), subacute sclerosing panencephalitis (SSPE), and myasthenia gravis (MG) were assayed for immune complexes. Three techniques were used: a modified Raji cell assay, the ¹²⁹-Clq polyethyleneglycol assay, and a solid-phase Clq assay. Immune complex levels were elevated in sera of some patients with MS, ALS, and SSPE, but the elevations were modest when compared with active systemic lupus erythematosus (SLE). In some cases, abnormalities were detected in only one assay system; in other cases, abnormalities were detected by two or three assay systems. In MS, immune complex elevations correlated with active disease and with decreased suppressor cell activity. Of two ALAS patients with antecedent poliomyelitis, one had markedly increased levels of immune complexes in two assays. In MG, levels of immune complexes did not differ from those of controls.

This article has been cited by other articles:

				A. Noronha Neutralizing antibodies to interferon Neurology, June 12, 2007; 68(24_suppl_4): S16 - S22. [Abstract] [Full Text] [PDF]

				R. A. Rudick, J. M. Bidlack, and D. W. Knutson Multiple Sclerosis: Cerebrospinal Fluid Immune Complexes That Bind Clq Arch Neurol, September 1, 1985; 42(9): 856 - 858. [Abstract] [PDF]